TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 179 filers reported holding TG THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $919,939 | -1.3% | 51,711 | -15.6% | 0.00% | 0.0% |
Q1 2024 | $932,130 | -83.3% | 61,284 | -81.2% | 0.00% | -81.8% |
Q4 2023 | $5,565,074 | +836.6% | 325,824 | +358.4% | 0.01% | +1000.0% |
Q3 2023 | $594,187 | -41.2% | 71,075 | +5.8% | 0.00% | -75.0% |
Q1 2023 | $1,010,372 | +2.7% | 67,179 | -19.2% | 0.00% | 0.0% |
Q4 2022 | $983,463 | +42.9% | 83,133 | -28.4% | 0.00% | +33.3% |
Q3 2022 | $688,000 | +173.0% | 116,138 | +774.6% | 0.00% | +200.0% |
Q4 2021 | $252,000 | -65.2% | 13,279 | -82.0% | 0.00% | -94.7% |
Q1 2020 | $724,000 | +134.3% | 73,590 | +106.2% | 0.02% | +533.3% |
Q2 2019 | $309,000 | +47.1% | 35,696 | +36.9% | 0.00% | +50.0% |
Q1 2019 | $210,000 | +12.3% | 26,075 | +83.6% | 0.00% | 0.0% |
Q2 2018 | $187,000 | -7.4% | 14,200 | -0.1% | 0.00% | -33.3% |
Q1 2018 | $202,000 | +37.4% | 14,219 | -20.9% | 0.00% | 0.0% |
Q4 2017 | $147,000 | -20.1% | 17,974 | -54.6% | 0.00% | -62.5% |
Q4 2016 | $184,000 | -34.3% | 39,605 | +68.5% | 0.01% | -74.2% |
Q4 2015 | $280,000 | – | 23,500 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Jetstream Capital LLC | 200,000 | $7,758,000 | 5.97% |
Lion Point Capital, LP | 609,128 | $23,628,000 | 4.08% |
RA Capital Management | 3,342,743 | $129,665,000 | 2.08% |
Ghost Tree Capital, LLC | 180,000 | $6,982,000 | 1.92% |
Nicholas Investment Partners, LP | 660,964 | $25,639,000 | 1.61% |
ARDSLEY ADVISORY PARTNERS LP | 350,000 | $13,577,000 | 1.60% |
SECTORAL ASSET MANAGEMENT INC | 414,949 | $16,096,000 | 1.30% |
Spotlight Asset Group, Inc. | 75,000 | $2,909,000 | 1.12% |
ACT CAPITAL MANAGEMENT, LLC | 55,000 | $2,134,000 | 1.10% |
Pier Capital, LLC | 280,486 | $10,880,000 | 1.09% |